압력 주입 백 시장 보고서 : 제품 유형, 소재, 용량, 용도, 최종 사용자별(2026-2034년)

The global pressure infusion bags market size reached USD 369.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 581.7 Million by 2034, exhibiting a growth rate (CAGR) of 5.02% during 2026-2034. The rising prevalence of chronic diseases, extensive research and development (R&D) activities, and the increasing geriatric population represent some of the key factors driving the market.

A pressure infusion bag is a special medical delivery device used to pressurize sterile parenteral fluids into patients. It is manufactured using nylon, later, and polyurethane materials that provide excellent visibility of the fluid bag levels. It is widely used for fast intravenous (IV) infusion, autotransfusion, invasive pressure monitoring, and fluid delivery during minimally invasive surgery. A pressure infusion bag is a safe, high-quality, reliable, and effective device for intravenous and intra-arterial infusion treatment. It is commonly used for patients suffering from trauma-induced and postpartum haemorrhage and cardiac surgery. It also helps to minimize the chances of cross-contamination during the fluid infusion process, thus making them an effective tool to ensure patient safety.

PRESSURE INFUSION BAGS MARKET TRENDS:

The rising prevalence of chronic diseases and the surge in emergency transfusion cases across the globe is one of the key factors driving the market growth. Pressure infusion bags are widely used in clinical emergencies, intensive care units (ICUs), anesthesia departments, and other clinical settings. In line with this, the widespread product adoption due to the growing importance of invasive pressure monitoring and assessment of wounds in arterial conditions is favoring the market growth. Additionally, the increasing product utilization within perioperative settings by anesthesiologists to control flow rates and enhance patient safety is acting as another growth-inducing factor. Apart from this, key players are focusing on the development of automated pressure infuser bags that assist in reducing manual infections and the possibility of accidental air embolism, which, in turn, is providing an impetus to the market growth. Moreover, the increasing demand for disposable pressure infuser bags prevents cross-contamination and eliminates costly cleaning and repairs of reusable bags is propelling the market growth. Besides this, the rising focus of manufacturers toward the upsurge in the demand for cost-effective and reliable products is positively influencing the market growth. Furthermore, the widespread product adoption in intra-arterial pressure monitoring and Swan-Ganz catheterization monitoring to slow the retrograde flow of blood and keep the indwelling catheter patent is providing a considerable boost to the market growth. Other factors, including extensive research and development (R&D) activities, significant expansion in the healthcare industry, the introduction of oval pressure infusion bags, increasing adoption of state-of-the-art medical facilities, and the rising geriatric population, are anticipated to drive the market further toward growth.

KEY MARKET SEGMENTATION:

Product Type Insights:

• Disposable
• Reusable

Material Insights:

• Nylon
• Polyurethane
• Latex
• Others

Capacity Insights:

• 500cc
• 1000cc
• 3000cc
• Above 3000cc

Application Insights:

• Blood and Drug Infusion
• Invasive Pressure Monitoring Procedures

End User Insights:

• Outpatient Facilities
• Hospitals and Clinics
• Others

Regional Insights:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for pressure infusion bags. Some of the factors driving the North America pressure infusion bags market included the rising geriatric population, the widespread utilization of disposable pressure infusion bags, and various product innovations.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global pressure infusion bags market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ASP Global LLC, Biegler GmbH, Eakin Healthcare Group Ltd, Friedrich Bosch GmbH & Co. KG, ICU Medical Inc.Merit Medical Systems Inc., Rudolf Riester GmbH (Halma plc), Sarstedt AG & Co. KG, SunMed LLC, Tapmedic LLC, VBM Medizintechnik GmbH, Vyaire Medical Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How has the global pressure infusion bags market performed so far and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global pressure infusion bags market?
• What are the key regional markets?
• Which countries represent the most attractive pressure infusion bags markets?
• What is the breakup of the market based on product type?
• What is the breakup of the market based on the material?
• What is the breakup of the market based on the capacity?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What is the competitive structure of the global pressure infusion bags market?
• Who are the key players/companies in the global pressure infusion bags market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Pressure Infusion Bags Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Disposable
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Reusable
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Material

• 7.1 Nylon
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Polyurethane
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Latex
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Capacity

• 8.1 500cc
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 1000cc
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 3000cc
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Above 3000cc
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Application

• 9.1 Blood and Drug Infusion
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Invasive Pressure Monitoring Procedures
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by End User

• 10.1 Outpatient Facilities
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Hospitals and Clinics
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Others
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Asia-Pacific
  • 11.2.1 China
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 Japan
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 India
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 South Korea
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Australia
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Indonesia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Europe
  • 11.3.1 Germany
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 France
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 United Kingdom
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 Italy
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Spain
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Russia
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Others
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Market Trends
  • 11.5.2 Market Breakup by Country
  • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

• 12.1 Overview
• 12.2 Drivers
• 12.3 Restraints
• 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 ASP Global LLC
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 Biegler GmbH
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
  • 16.3.3 Eakin Healthcare Group Ltd
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
  • 16.3.4 Friedrich Bosch GmbH & Co. KG
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
  • 16.3.5 ICU Medical Inc.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Merit Medical Systems Inc.
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 Rudolf Riester GmbH (Halma plc)
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Sarstedt AG & Co. KG
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 SunMed LLC
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
  • 16.3.10 Tapmedic LLC
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
  • 16.3.11 VBM Medizintechnik GmbH
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Vyaire Medical Inc.
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio